Susquehanna International Group
IBER

Susquehanna International Group’s Ibere Pharmaceuticals IBER Stock Holding History

Susquehanna International Group’s Portfolio IBER Stock Details IBER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,367
Closed -$296K – 14089
2022
Q4 		$296K Hold
29,367
– – ﹤0.01% 9130
2022
Q3 		$291K Buy
+29,367
New +$290K ﹤0.01% 9873

Susquehanna International Group's IBER Position: Q1 2023 in Review

Susquehanna International Group sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 29,367 shares — an estimated $296K sold.

Susquehanna International Group first reported a position in IBER in Q3 2022 and held it in 2 quarters. The position peaked at $296K in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

  • Susquehanna International Group reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 29,367 Ibere Pharmaceuticals shares in Q1 2023, an estimated $296K.
  • Susquehanna International Group first reported a position in Ibere Pharmaceuticals in Q3 2022 and held it in 2 quarters.
  • Susquehanna International Group's Ibere Pharmaceuticals position peaked at $296K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.